about
Combined Effects of Muricid Extract and 5-Fluorouracil on Intestinal Toxicity in Rats.Dipeptidyl peptidases and inflammatory bowel disease.Growth factor based therapies and intestinal disease: is glucagon-like peptide-2 the new way forward?Emerging evidence on the pathobiology of mucositis.In vitro development and validation of a non-invasive (13)C-stable isotope assay for ornithine decarboxylase.Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein.From blood to breath: New horizons for esophageal cancer biomarkers.Effects of Streptococcus thermophilus TH-4 in a rat model of doxorubicin-induced mucositis.Indigenous Health: ACTION on Prevention - 50th annual Australian Society for Medical Research National Scientific Conference.Biochemical and histological changes in the small intestine of mice with dextran sulfate sodium colitisDipeptidyl peptidase expression during experimental colitis in miceTeduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndromeGastrointestinal pathology in a mouse model of mucopolysaccharidosis type IIIAComplementary medicines: emerging therapies for intestinal mucositisNon-invasive detection of a palifermin-mediated adaptive response following chemotherapy-induced damage to the distal small intestine of ratsThe Use of Selected Ion Flow Tube-Mass Spectrometry Technology to Identify Breath Volatile Organic Compounds for the Detection of Head and Neck Squamous Cell Carcinoma: A Pilot StudyEffects of Streptococcus thermophilus TH-4 on intestinal mucositis induced by the chemotherapeutic agent 5-Fluorouracil (5-FU)
P50
Q35649627-3E899007-AEFF-4A0A-BF21-23CFAF5628A2Q36478618-15C690B4-3A7F-4139-8B28-4F3EB747E4F6Q37424465-43DD6C69-388C-4B90-9621-2E0BC9B013DCQ38120647-70607C06-0693-4CB8-B840-E065323E08F4Q38773761-24D813F4-B293-48B6-AFE6-689F5EDF5C7FQ39377477-8B8A0C85-0AD0-41B5-8F02-D816E569E551Q42353202-DF18FB7F-2340-4446-9228-E3CF1A182410Q43889083-C3651A9E-EB83-465F-8C98-22958AFFBB47Q51192810-E6B171DF-DDEE-4E02-9D7F-6513E6C9124FQ57119177-487658FE-ACC0-494A-96CA-ECBF0A9C4ECAQ58448139-1323D9B6-469D-475A-9AEF-93B469EE348CQ82868455-EAE6AB70-A8CC-4B41-AB07-E299D8653304Q83240223-A0F4984D-7DE1-4779-979D-FBA0277D454EQ84294604-4687BCFF-EE5B-4513-9D01-6EE1A863CC13Q84448103-E4F90CD9-A985-43FC-B896-44FAAF5191D1Q93048427-3E01AB8D-10C5-447A-9AC8-1E2FBC440B7DQ95793653-D926A905-404F-43B8-8A1D-3579E64F7427
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Roger Yazbeck
@en
Roger Yazbeck
@nl
type
label
Roger Yazbeck
@en
Roger Yazbeck
@nl
prefLabel
Roger Yazbeck
@en
Roger Yazbeck
@nl
P31
P496
0000-0002-1038-4998